Equities

Bright Green Corp

BGXX:NAQ

Bright Green Corp

Actions
  • Price (USD)0.2209
  • Today's Change0.006 / 2.94%
  • Shares traded383.82k
  • 1 Year change-80.96%
  • Beta--
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

  • Revenue in USD (TTM)0.00
  • Net income in USD-13.13m
  • Incorporated2019
  • Employees5.00
  • Location
    Bright Green Corp401 East Las Olas Blvd., Suite 1400FT LAUDERDALE 33301United StatesUSA
  • Phone+1 (201) 370-1140
  • Fax+1 (302) 636-5454
  • Websitehttps://brightgreen.us/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BGXX:NAQ since
announced
Transaction
value
C2 Wellness CorpAnnounced25 Jan 202425 Jan 2024Announced-7.96%1.20m
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Janone Inc0.00-17.10m38.60m5.00---------3.52-0.45640.002.260.00----0.00-52.40-23.12-96.58-62.22--23.38---30.14----0.0594-------313.15------
Incannex Healthcare Inc163.39k-13.70m38.89m----2.06--238.01-0.3806-0.38060.00031.190.0038--0.0554---31.42-54.94-32.90-59.47-----8,386.19-1,033.07----0.00--61.923.38-24.35--54.12--
Unicycive Therapeutics Inc675.00k-31.41m39.27m14.00------58.18-1.62-1.620.0276-0.10960.0794----48,214.29-359.15-218.20---609.54-----4,525.04-3,877.49---------29.02---73.95------
Movano Inc0.00-29.28m39.31m30.00--6.48-----0.6463-0.64630.000.06180.00----0.00-258.41-151.50-496.87-188.58--------1.26--0.014------3.45--4.24--
Quince Therapeutics Inc0.00-31.39m39.33m32.00--0.4596-----0.8424-0.84240.001.980.00----0.00-23.09-42.72-24.22-46.06------------0.1363------39.25---5.47--
Estrella Immunopharma Inc0.00-2.16m39.54m----3.78-----1.90-1.900.000.28610.00-------5.92---7.86--------------0.00-------302.11------
Natural Alternatives International, Inc.127.76m-4.11m39.64m317.00--0.463988.080.3103-0.705-0.70521.8714.030.86244.2312.32403,041.00-2.774.90-3.115.937.9015.98-3.223.802.59-2.540.09880.00-9.913.06-76.46-20.7427.08--
Cara Therapeutics Inc20.97m-118.51m40.08m55.00--0.6997--1.91-2.19-2.190.38721.050.13612.376.96381,236.40-76.94-35.76-91.50-40.8270.56---565.21-162.104.43--0.00---49.929.26-38.65--100.66--
Bright Green Corp0.00-13.13m40.81m5.00--3.62-----0.0732-0.07320.000.05940.00----0.00-64.24---97.68-------------5,488.510.0181------52.54------
ImmuCell Corp17.47m-5.77m41.08m79.00--1.63--2.35-0.7454-0.74542.263.220.39411.968.86221,160.40-13.03-5.16-14.19-5.5322.1540.04-33.05-12.640.8715-15.170.3238---5.909.72-131.56---1.39--
Dyadic International Inc2.90m-6.80m41.81m7.00--7.01--14.42-0.2359-0.23590.10070.2040.2643--7.28414,115.70-61.97-36.82-78.87-39.8531.8422.47-234.42-410.16----0.00---1.0717.4830.20------
SensaSure Technologies Inc1.15k-1.94m42.26m1.00------36,749.47-0.0344-0.03440.00002-0.0110.0336----1,150.00-5,689.09-----------169,534.80-----2.71-----31.15--17.62------
Bolt Biotherapeutics Inc7.88m-69.20m42.32m100.00--0.3753--5.37-1.83-1.830.20832.960.0406----78,760.00-35.71-48.32-40.23-54.03-----878.58-2,267.00----0.00--37.48--21.45---6.61--
Benson Hill Inc473.34m-111.25m42.42m270.00--0.4846--0.0896-0.5914-0.61312.520.41291.2210.2714.811,753,096.00-28.68---38.28--4.993.18-23.50-40.730.9166-2.330.4509--24.16156.43-11.58--63.78--
Carmell Corp0.00-16.88m42.71m9.00--1.92-----1.53-1.460.001.07------0.00--------58.60---------194.460.0495-------75.70------
Cyclo Therapeutics Inc1.08m-20.06m43.07m8.00--9.00--40.02-1.33-1.330.06790.16660.12330.38712.14134,551.30-229.72-132.22-727.50-215.1790.8590.37-1,863.35-1,114.041.42-2,769.340.00---21.761.25-29.81---3.95--
Data as of May 09 2024. Currency figures normalised to Bright Green Corp's reporting currency: US Dollar USD

Institutional shareholders

5.22%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20233.46m1.88%
The Vanguard Group, Inc.as of 31 Dec 20232.57m1.40%
Geode Capital Management LLCas of 31 Dec 20231.24m0.68%
SSgA Funds Management, Inc.as of 31 Dec 20231.00m0.55%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023527.71k0.29%
Morgan Stanley & Co. LLCas of 31 Dec 2023211.16k0.12%
Charles Schwab Investment Management, Inc.as of 31 Dec 2023166.41k0.09%
The Bank of New York Mellon Corp. (Investment Management)as of 31 Mar 2024163.80k0.09%
BlackRock Investment Management LLCas of 31 Dec 2023151.03k0.08%
Old Mission Capital LLCas of 31 Dec 2023107.07k0.06%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.